TruAlt Bioenergy IPO
mainboardListed
GMP
₹90

mainboardListed
TruAlt Bioenergy IPO
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹90
(+18.15%) Est. Gain
Investment Timeline
✓
IPO Open
25 Sept 2025
✓
IPO Close
29 Sept 2025
✓
Allotment
30 Sept 2025
✓
Listing
3 Oct 2025
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
CONSIDER APPLYING
64.9/100
🎯 Application Strategy
Action: 👍 CONSIDER - Decent opportunity for diversification
Lots: Apply 1-2 lots based on risk appetite
⏳ Timing Advice
⏰ Apply by DAY 2 NOON - High demand, good allotment still possible
Key Factor Analysis
🚀
Demand
🚀 Exceptional subscription! Massive oversubscription across all categories
💰
Valuation
⚠️ Expensive valuation - limited room for gains
📈
Listing
📈 Moderate listing gains possible (5-12%)
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹472.0 - ₹496.0
📦Lot Size
30 shares
💰Issue Size
₹839.28 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of TruAlt Bioenergy IPO?
As of today, the Grey Market Premium (GMP) for TruAlt Bioenergy IPO is ₹90, which is approximately (+18.15%) of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for TruAlt Bioenergy IPO?
Our AI algorithm currently rates this IPO as "CONSIDER APPLYING" with a score of 64.9/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for TruAlt Bioenergy IPO be announced?
The allotment status for TruAlt Bioenergy IPO is expected to be finalized on 30 Sept 2025. Investors can check their status on the registrar's website.
What is the listing date for TruAlt Bioenergy IPO?
Shares of TruAlt Bioenergy IPO are proposed to be listed on stock exchanges on 3 Oct 2025.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.